Elective cardiac retransplantation: A viable option that can be repeated Hannah Copeland, MD, Romana Coelho-Anderson, RN, CCTC, Nicole Mineburg, RN, CCTC,

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Lobar lung transplantation: One size fits all

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

Improving health care by embracing Systems Theory

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Abracadabra I, II…HeartMate 3?

William M. DeCampli, MD, PhD

Long-term patient and allograft outcomes of renal transplant recipients undergoing cardiac surgery Rodolfo V. Rocha, MD, Diana Zaldonis, MPH, Vinay Badhwar,

Marye J. Gleva, MD, Charles B. Huddleston, MD

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

The lord of the rings Antonio Miceli, MD, PhD

Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery Pedro J.

Conduit conundrum: If not two, why three?

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Elective cardiac retransplantation: A viable option that can be repeated Hannah Copeland, MD, Romana Coelho-Anderson, RN, CCTC, Nicole Mineburg, RN, CCTC,

Support Your Specialty

Michael Mack, MD, David Taggart, MD

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Michele Gallo, MD, Gino Gerosa, MD

Bartley P. Griffith, MD, FACS, FRCS

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Confusion still exists regarding postoperative delirium and its etiology after esophagectomy Robert B. Cameron, MD The Journal of Thoracic and Cardiovascular.

Stephen R. Broderick, MD, MPHS

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Impact of low donor to recipient weight ratios on cardiac transplantation Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Daniel T. Engelman, MD, FACS, Michael J. Germain, MD

Long-term survival in lung transplant recipients after successful preoperative coronary revascularization Leonardo Seoane, MD, Lee M. Arcement, MD, Vincent.

A fate worse than death Jennifer S. Lawton, MD

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

The harder one looks, the more one finds

Is single-dose prophylactic gentamicin associated with acute kidney injury in patients undergoing cardiac surgery? A matched-pair analysis Dorthe Viemose.

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Early extubation after cardiac surgery: The evolution continues

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Commentary: “Isn't cardiac surgery a team sport?”

Bicuspid aortopathy: Seeing the forest for the trees

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

Heidi Goerler, MD, Andre Simon, MD, Gregor Warnecke, MD, Anna L

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

First in line for robotic surgery: Would you want to know?

Should heart transplantation be considered as a treatment option for patients aged 70 years and older? Jeffrey A Morgan, MD, Ranjit John, MD, Donna M.

Preoperative PFTs: The answer is blowing in the wind

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Lessons learned from Melody valve retrieved at transplantation

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Edward Y. Chan, MD, Michael J. Reardon, MD

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Presentation transcript:

Elective cardiac retransplantation: A viable option that can be repeated Hannah Copeland, MD, Romana Coelho-Anderson, RN, CCTC, Nicole Mineburg, RN, CCTC, Michael McCarthy, BS, Jack G. Copeland, MD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 3, Pages 822-827 (March 2011) DOI: 10.1016/j.jtcvs.2010.11.027 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Patient survival: 818 patients undergoing primary transplantation are shown in blue, and 23 patients undergoing elective retransplantation are shown in green. Tx, Transplantation. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 822-827DOI: (10.1016/j.jtcvs.2010.11.027) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Freedom from rejection: patients undergoing primary transplantation are shown in blue, and patients undergoing retransplantation are shown in green. Tx, Transplantation; ReTx, retransplantation. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 822-827DOI: (10.1016/j.jtcvs.2010.11.027) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Freedom from serum creatinine level of greater than 2.25 ml/dL for primary transplant recipients (blue) and retransplant recipients (green). Tx, Transplantation; ReTx, retransplantation. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 822-827DOI: (10.1016/j.jtcvs.2010.11.027) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Freedom from leukopenia (<3500 white blood cells/mL) for primary transplant recipients (blue) and retransplant recipients (green). Tx, Transplantation; ReTx, retransplantation. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 822-827DOI: (10.1016/j.jtcvs.2010.11.027) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions